Max Drawdown (5Y) Chart

View Max Drawdown (5Y) for ORINF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Max Drawdown (5Y) Chart
Start Trial

Historical Max Drawdown (5Y) Data

View and export this data back to 2005. Start Trial.
Date Value
May 31, 2026 20.69%
April 30, 2026 20.69%
March 31, 2026 20.69%
February 28, 2026 20.69%
January 31, 2026 20.69%
December 31, 2025 20.69%
November 30, 2025 20.69%
October 31, 2025 20.69%
September 30, 2025 20.69%
August 31, 2025 20.69%
July 31, 2025 20.69%
June 30, 2025 20.69%
May 31, 2025 20.69%
April 30, 2025 20.69%
March 31, 2025 20.69%
February 28, 2025 24.40%
January 31, 2025 24.40%
December 31, 2024 24.40%
November 30, 2024 24.40%
October 31, 2024 24.40%
September 30, 2024 24.40%
August 31, 2024 24.40%
July 31, 2024 24.40%
June 30, 2024 24.40%
May 31, 2024 24.40%
Date Value
April 30, 2024 24.40%
March 31, 2024 24.40%
February 29, 2024 24.40%
January 31, 2024 24.40%
December 31, 2023 24.40%
November 30, 2023 24.40%
October 31, 2023 24.40%
September 30, 2023 24.40%
August 31, 2023 24.40%
July 31, 2023 37.60%
June 30, 2023 37.60%
May 31, 2023 37.60%
April 30, 2023 37.60%
March 31, 2023 37.60%
February 28, 2023 37.60%
January 31, 2023 37.60%
December 31, 2022 37.60%
November 30, 2022 37.60%
October 31, 2022 37.60%
September 30, 2022 37.60%
August 31, 2022 37.60%
July 31, 2022 37.60%
June 30, 2022 37.60%
May 31, 2022 37.60%
April 30, 2022 37.60%

Max Drawdown Definition

Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.

Read full definition.

Max Drawdown (5Y) Range, Past 5 Years

View Max Drawdown (5Y) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Max Drawdown (5Y) Benchmarks

View Max Drawdown (5Y) Benchmarks
Start Trial
AstraZeneca PLC 27.87%
ANI Pharmaceuticals, Inc. 72.96%
Corcept Therapeutics, Inc. 71.85%
Assertio Holdings, Inc. 99.16%
Veru, Inc. 99.12%